X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ALEMBIC LTD SHASUN PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 123.9 77.1 160.7% View Chart
P/BV x 8.5 2.9 297.9% View Chart
Dividend Yield % 0.2 0.4 59.5%  

Financials

 SHASUN PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ALEMBIC LTD
Mar-16
SHASUN PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs9453 178.4%   
Low Rs4629 155.6%   
Sales per share (Unadj.) Rs214.24.7 4,538.0%  
Earnings per share (Unadj.) Rs5.38.8 60.8%  
Cash flow per share (Unadj.) Rs15.89.0 175.7%  
Dividends per share (Unadj.) Rs1.000.15 666.7%  
Dividend yield (eoy) %1.40.4 391.5%  
Book value per share (Unadj.) Rs53.327.7 192.4%  
Shares outstanding (eoy) m56.62267.03 21.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.38.7 3.8%   
Avg P/E ratio x13.14.7 280.0%  
P/CF ratio (eoy) x4.44.6 96.9%  
Price / Book Value ratio x1.31.5 88.5%  
Dividend payout %18.71.7 1,096.2%   
Avg Mkt Cap Rs m3,95810,962 36.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,164238 909.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1271,260 962.2%  
Other income Rs m229264 86.9%   
Total revenues Rs m12,3561,524 810.7%   
Gross profit Rs m1,00983 1,218.7%  
Depreciation Rs m59461 966.8%   
Interest Rs m4150 138,366.7%   
Profit before tax Rs m230285 80.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 -0.0%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m-736 -1,192.1%   
Profit after tax Rs m3022,343 12.9%  
Gross profit margin %8.36.6 126.7%  
Effective tax rate %-31.72.1 -1,478.6%   
Net profit margin %2.5185.9 1.3%  
BALANCE SHEET DATA
Current assets Rs m6,8841,689 407.7%   
Current liabilities Rs m8,456486 1,739.2%   
Net working cap to sales %-13.095.4 -13.6%  
Current ratio x0.83.5 23.4%  
Inventory Days Days62217 28.4%  
Debtors Days Days10881 132.7%  
Net fixed assets Rs m4,9701,624 306.0%   
Share capital Rs m113534 21.2%   
"Free" reserves Rs m2,8755,960 48.2%   
Net worth Rs m3,0207,404 40.8%   
Long term debt Rs m1,817104 1,742.5%   
Total assets Rs m13,3478,010 166.6%  
Interest coverage x1.6950.7 0.2%   
Debt to equity ratio x0.60 4,271.6%  
Sales to assets ratio x0.90.2 577.5%   
Return on assets %5.429.3 18.4%  
Return on equity %10.031.6 31.6%  
Return on capital %13.331.3 42.6%  
Exports to sales %46.42.9 1,574.7%   
Imports to sales %14.228.9 49.4%   
Exports (fob) Rs m5,62237 15,152.3%   
Imports (cif) Rs m1,728364 475.0%   
Fx inflow Rs m5,84337 15,748.2%   
Fx outflow Rs m2,173365 595.5%   
Net fx Rs m3,669-328 -1,119.3%   
CASH FLOW
From Operations Rs m398346 115.0%  
From Investments Rs m-1,635-48 3,434.9%  
From Financial Activity Rs m1,309-301 -434.8%  
Net Cashflow Rs m71-3 -2,373.3%  

Share Holding

Indian Promoters % 39.2 64.0 61.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.2 1,800.0%  
FIIs % 17.6 9.7 181.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.1 151.7%  
Shareholders   20,750 54,701 37.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ELDER PHARMA  FDC LTD.  ORCHID PHARMA LTD  DISHMAN PHARMA  TTK HEALTHCARE  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - FDC LTD. COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS